ABT-363

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameABT-363
Drug Alias NameABT-363
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor agonists
TargetsSphingosine 1-phosphate receptor
Therapy Area/IndicationsLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Laboratories
Inactive CompaniesN/A
Active IndicationsLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A